Sparrow Pharmaceuticals, Inc.

New Filing
CIK: 0001786949·Pharmaceuticals·DELAWARE·Filed: Jan 13, 2021
Total Offering

$50,825,257

Amount Sold

$1,075,255

Investors

15

First Sale

Dec 31, 2020

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
David Katz
Related Person
Robert Jacks
Related Person
Peter Thompson
Related Person
Klaus Veitinger
Related Person

Company

Sparrow Pharmaceuticals, Inc.

920 SW 6TH AVE

PORTLAND, OR, 97204

312-752-8446

SEC Filing

0001786949-21-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Sparrow Pharmaceuticals, Inc. Form D Filing — $50,825,257 | FilingFlow